DXCM : Summary for DexCom, Inc. - Yahoo Finance

U.S. Markets closed

DexCom, Inc. (DXCM)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
74.89-0.34 (-0.45%)
At close: 4:00PM EDT

74.89 0.00 (0.00%)
After hours: 4:19PM EDT

People also watch
PODDNUVAABMDELGXEW
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close75.23
Open76.39
Bid74.50 x 400
Ask84.98 x 100
Day's Range74.81 - 76.82
52 Week Range57.68 - 96.38
Volume853,813
Avg. Volume841,433
Market Cap6.46B
Beta0.59
PE Ratio (TTM)-95.40
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Dexcom Has a Big Ally if Apple Gets Into Its Corner of the Diabetes Market
    Bloomberg6 days ago

    Dexcom Has a Big Ally if Apple Gets Into Its Corner of the Diabetes Market

    Apple may be exploring ways to monitor glucose levels, but Alphabet's efforts show it's a tough slog.

  • American City Business Journals10 days ago

    Dexcom adding 500 jobs in Mesa

    Dexcom Inc. (DXCM), a San Diego-based manufacturer of continuous glucose monitoring for patients with diabetes, has expanded into a new manufacturing facility in Mesa. The 180,000-square-foot facility will support the company's global manufacturing operations and is projected to create more than 500 jobs over the next several years. A ribbon-cutting ceremony is scheduled for April 25 at the new facility, 232 S. Dobson Road, Mesa, which is its second manufacturing plant.

  • Is Medtronic's Artificial Pancreas the Next Big Thing in Diabetes?
    Motley Fool11 days ago

    Is Medtronic's Artificial Pancreas the Next Big Thing in Diabetes?

    Medtronic's MiniMed 670G could reduce the burden on Type 1 diabetes patients, as well as slow diabetes progression by keeping blood glucose levels on target.